Search Within

Samuel Aaron Funt

Formats
  1. Meeting Abstract (72)
  2. Journal Article (61)
  3. Review (3)
  4. Correspondence (2)
  5. Editorial (1)
Groups
  1. Department of Medicine (139)
  2. Genitourinary Oncology Service (139)
  3. Solid Tumor Oncology Division (139)
  4. Weinberg Fellows (139)
  5. Department of Pathology and Laboratory Medicine (74)
  6. Surgery (60)

More Groups

People
  1. Dean Bajorin (90)
  2. Jonathan Rosenberg (75)
  3. Gopakumar Iyer (66)
  4. Hikmat Al-Ahmadie (54)
  5. Darren Feldman (47)
  6. Min Yuen Teo (47)

More People

Years
  1. 2025 (6)
  2. 2024 (19)
  3. 2023 (13)
  4. 2022 (19)
  5. 2021 (19)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (72)
  2. Annals of Oncology (4)
  3. Clinical Cancer Research (4)
  4. European Urology (3)
  5. JCO Precision Oncology (3)
  6. Nature Communications (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. Elsevier Science, Inc. (8)
  3. Nature Publishing Group (7)
  4. American Association for Cancer Research (6)
  5. Elsevier Inc. (6)
  6. Oxford University Press (5)

More Publishers

Results (139)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cutaneous toxicity and clinical outcomes with enfortumab vedotin and pembrolizumab in patients with locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Arbuiso, A.; Sternschuss, M.; Whiting, K.; Gupta, A.; Huttenlocher Bent, E.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Arbuiso, A.; Gupta, A.; Bent, E. H.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Quality of informed consent via telemedicine compared with in-person for clinical cancer research
    Journal Article

    Sternschuss, M.; Lattanzi, M.; Vertosick, E.; Austria, M.; Martin, S.; Regazzi, A.; Buckely, M. T.; Lengfellner, J.; Riely, G. J.; Solit, D. B.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma
    Journal Article

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N. M.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors
    Journal Article

    Matulewicz, R. S.; Baky, F.; Liso, N.; Williams, B. M.; Porwal, S.; Assel, M.; Carver, B. S.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)
    Meeting Abstract

    Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Stereotactic radiosurgery and whole brain radiotherapy for germ cell tumor brain metastases: Practice patterns and outcomes
    Meeting Abstract

    Gui, C.; Funt, S.; Boe, L. A.; Yu, Y.; Zinovoy, M.; Chen, L.; Yamada, Y.; Pike, L. R. G.; Feldman, D.; Imber, B. S.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Long-term outcomes of regressed or “burnt out” primary testicular germ cell tumors
    Journal Article

    Baky, F. J.; Liso, N.; Williams, B.; Reuter, V. E.; Tickoo, S. K.; Feldman, D. R.; Funt, S. A.; Carver, B. S.; Sheinfeld, J.; Matulewicz, R. S.
    Urology (2024)

    Fulltext@MSK | Save
  • Long-term clinical outcomes of patients with negative pathology (pN0) at primary retroperitoneal lymph node dissection
    Journal Article

    Baky, F.; Liso, N.; Williams, B.; Knezevic, A.; Funt, S. A.; Feldman, D. R.; Carver, B.; Sheinfeld, J.; Matulewicz, R. S.
    Clinical Genitourinary Cancer (2024)

    Fulltext@MSK | Save